3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
5
Colorectal Neoplasms
3
Brain Neoplasms
3
Rectal Neoplasms
2
Pain, Postoperative
2
Neurotoxicity Syndromes
2
Neoplasms
2
Mesothelioma
2
Colonic Neoplasms
2
Agnosia
2
Urinary Bladder Neoplasms
1
Upper Abdominal Cancer Surgery
1
Thyroid Neoplasms
1
Supratentorial Brain Tumor
1
Stomach Neoplasms
1
Seizures
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Primary Immunodeficiency Diseases
1
Pain
1
Paclitaxel-induced Neuropathy
1
Myoma
1
Leukemia, Myeloid, Acute
1
Infections
1
Head and Neck Neoplasms
1
Epstein-Barr Virus Infections
1
Colorectal Cancer Screening
1
Anesthesia
1
Interventions
Levetiracetam
6
Cannabidiol
4
perampanel
2
Standard of Care
2
Everolimus
2
enzalutamide
1
Vigabatrin
1
Tranexamic Acid
1
Temozolomide
1
Sodium Chloride
1
Saline Solution
1
Pregabalin
1
Medical Marijuana
1
Magnesium Sulfate
1
Drug Therapy
1
Curcumin
1
Cholecalciferol
1
Aspirin
1
Anticonvulsants
1
Anastrozole
1
Airway Extubation
1
2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Seizures
×
Magnesium Sulfate
×
Clear all
NCT01601314
2018-01-17
MAGNA
Fundacion Clinic per a la Recerca Biomédica
Phase 3
Completed
55 enrolled